{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:18:56Z","timestamp":1780593536982,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/pr.2017.156","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T16:01:11Z","timestamp":1498838471000},"page":"806-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Neonatal adaptation following intrauterine antidepressant exposure: assessment, drug assay levels, and infant development outcomes"],"prefix":"10.1038","volume":"82","author":[{"given":"Megan","family":"Galbally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolland","family":"Kohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Lappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"BFpr2017156_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","volume":"335","author":"CD Chambers","year":"1996","unstructured":"Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL . Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010\u20135.","journal-title":"N Engl J Med"},{"key":"BFpr2017156_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/00048670903107583","volume":"43","author":"M Galbally","year":"2009","unstructured":"Galbally M, Lewis AJ, Lum J, Buist A . Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study. Aust N Z J Psychiatry 2009;43:846\u201354.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFpr2017156_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","volume":"156","author":"AM Costei","year":"2002","unstructured":"Costei AM, Kozer E, Ho T, Ito S, Koren G . Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129\u201332.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BFpr2017156_CR4","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.4088\/JCP.12r07967","volume":"74","author":"S Grigoriadis","year":"2013","unstructured":"Grigoriadis S, VonderPorten EH, Mamisashvili L et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry 2013;74:e309\u201320.","journal-title":"J Clin Psychiatry"},{"key":"BFpr2017156_CR5","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan LP, Connaughton Jr JF, Kron RE, Emich JP . Neonatal abstinence syndrome: assessment and management. Addict Dis 1975;2:141\u201358.","journal-title":"Addict Dis"},{"key":"BFpr2017156_CR6","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3109\/14767058.2014.977247","volume":"28","author":"N Kieviet","year":"2015","unstructured":"Kieviet N, van Ravenhorst M, Dolman KM et al. Adapted Finnegan scoring list for observation of anti-depressant exposed infants. J Matern Fetal Neonatal Med 2015;28:2010\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"BFpr2017156_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1360-0443.2009.02802.x","volume":"105","author":"U Zimmermann-Baer","year":"2010","unstructured":"Zimmermann-Baer U, N\u00f6tzli U, Rentsch K, Bucher HU . Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction 2010;105:524\u20138.","journal-title":"Addiction"},{"key":"BFpr2017156_CR8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","volume":"60","author":"K Laine","year":"2003","unstructured":"Laine K, Heikkinen T, Ekblad U, Kero P . Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003;60:720\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"BFpr2017156_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1176\/ajp.148.6.705","volume":"148","author":"H Sternbach","year":"1991","unstructured":"Sternbach H . The serotonin syndrome. Am J Psychiatry 1991;148:705\u201313.","journal-title":"Am J Psychiatry"},{"key":"BFpr2017156_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4088\/JCP.v65n0214","volume":"65","author":"TF Oberlander","year":"2004","unstructured":"Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W . Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004;65:230\u20137.","journal-title":"J Clin Psychiatry"},{"key":"BFpr2017156_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0028-1103296","volume":"42","author":"J Rampono","year":"2009","unstructured":"Rampono J, Simmer K, Ilett KF et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 2009;42:95\u2013100.","journal-title":"Pharmacopsychiatry"},{"key":"BFpr2017156_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/FTD.0b013e3181a58fb4","volume":"31","author":"N Boucher","year":"2009","unstructured":"Boucher N, Koren G, Beaulac-Baillargeon L . Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations. Ther Drug Monit 2009;31:404\u20139.","journal-title":"Ther Drug Monit"},{"key":"BFpr2017156_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/neu.2016.30","volume":"29","author":"N Kieviet","year":"2017","unstructured":"Kieviet N, van Keulen V, van de Ven PM, Dolman KM, Deckers M, Honig A . Serotonin and poor neonatal adaptation after antidepressant exposure in utero. Acta Neuropsychiatr 2017;29:43\u201353.","journal-title":"Acta Neuropsychiatr"},{"key":"BFpr2017156_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/00048670903559593","volume":"44","author":"AJ Lewis","year":"2010","unstructured":"Lewis AJ, Galbally M, Opie G, Buist A . Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry 2010;44:482\u20137.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFpr2017156_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0004867415569800","volume":"49","author":"M Galbally","year":"2015","unstructured":"Galbally M, Lewis AJ, Buist A . Child developmental outcomes in preschool children following antidepressant exposure in pregnancy. Aust N Z J Psychiatry 2015;49:642\u201350.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFpr2017156_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/jp.2010.211","volume":"31","author":"G Klinger","year":"2011","unstructured":"Klinger G, Frankenthal D, Merlob P et al. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. J Perinatol 2011;31:615\u201320.","journal-title":"J Perinatol"},{"issue":"4","key":"BFpr2017156_CR17","doi-asserted-by":"publisher","first-page":"e1558","DOI":"10.1002\/mpr.1558","volume":"26","author":"Megan Galbally","year":"2017","unstructured":"Galbally M, van IJzendoorn M, Permezel M, Saffery R, Lappas M, Ryan J . Mercy Pregnancy and Emotional Well-being Study (MPEWS): understanding maternal mental health, fetal programming and child development. Study design and cohort profile. Int J Methods Psychiatr Res 2017; e1558.","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"BFpr2017156_CR18","doi-asserted-by":"crossref","unstructured":"Procyshyn RM, Bezchlibnyk-Butler KZ, Jeffries JJ Clinical Handbook of Psychotropic Drugs. Hogrefe Publishing: Toronto, Canada, 2015.","DOI":"10.1027\/00474-000"},{"key":"BFpr2017156_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","volume":"31","author":"M Reis","year":"2009","unstructured":"Reis M, Aamo T, Spigset O, Ahlner J . Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 2009;31:42\u201356.","journal-title":"Ther Drug Monit"},{"key":"BFpr2017156_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jchromb.2015.10.029","volume":"1006","author":"TN Andreassen","year":"2015","unstructured":"Andreassen TN, Falch BM, Spigset O . A UPLC-MSMS method for the analysis of olanzapine in serum-with particular emphasis on drug stability testing. J Chromatogr B Analyt Technol Biomed Life Sci 2015;1006:112\u201320.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BFpr2017156_CR21","first-page":"195","volume":"21","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 2011;21:195\u2013235.","journal-title":"Pharmacopsychiatry"},{"key":"BFpr2017156_CR22","first-page":"353","volume":"8","author":"K Kaltenbach","year":"1986","unstructured":"Kaltenbach K, Finnegan LP . Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol 1986;8:353\u20135.","journal-title":"Neurobehav Toxicol Teratol"},{"key":"BFpr2017156_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.earlhumdev.2009.03.001","volume":"85","author":"JM Kerstjens","year":"2009","unstructured":"Kerstjens JM, Bos AF, ten Vergert EM, de Meer G, Butcher PR, Reijneveld SA . Support for the global feasibility of the Ages and Stages Questionnaire as developmental screener. Early Hum Dev 2009;85:443\u20137.","journal-title":"Early Hum Dev"},{"key":"BFpr2017156_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/S1092852900027449","volume":"15","author":"S Gentile","year":"2010","unstructured":"Gentile S . On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr 2010;15:167\u201385.","journal-title":"CNS Spectr"},{"key":"BFpr2017156_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0890334411429782","volume":"28","author":"JR Gorman","year":"2012","unstructured":"Gorman JR, Kao K, Chambers CD . Breastfeeding among women exposed to antidepressants during pregnancy. J Hum Lact 2012;28:181\u20138.","journal-title":"J Hum Lact"},{"key":"BFpr2017156_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00213-011-2270-z","volume":"217","author":"RC Casper","year":"2011","unstructured":"Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni L . Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology 2011;217:211\u2013219.","journal-title":"Psychopharmacology"},{"key":"BFpr2017156_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.earlhumdev.2012.12.012","volume":"89","author":"GE Hanley","year":"2013","unstructured":"Hanley GE, Brain U, Oberlander TF . Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Hum Dev 2013;89:519\u201324.","journal-title":"Early Hum Dev"},{"key":"BFpr2017156_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1067\/mpd.2003.139","volume":"142","author":"RC Casper","year":"2003","unstructured":"Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A . Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003;142:402\u20138.","journal-title":"J Pediatr"},{"key":"BFpr2017156_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/00048674.2010.549995","volume":"45","author":"M Galbally","year":"2011","unstructured":"Galbally M, Lewis AJ, Buist A . Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry 2011;45:393\u20139.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2 Suppl","key":"BFpr2017156_CR30","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jadohealth.2012.04.009","volume":"51","author":"TF Oberlander","year":"2012","unstructured":"Oberlander TF . Fetal serotonin signaling: setting pathways for early childhood development and behavior. J Adolesc Health 2012;51 (2 Suppl): S9\u201316.","journal-title":"J Adolesc Health"},{"key":"BFpr2017156_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.earlhumdev.2015.06.005","volume":"91","author":"M Yoshida","year":"2015","unstructured":"Yoshida M, Shinohara H, Kodama H . Assessment of nocturnal sleep architecture by actigraphy and one-channel electroencephalography in early infancy. Early Hum Dev 2015;91:519\u2013526.","journal-title":"Early Hum Dev"},{"key":"BFpr2017156_CR32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1467-8624.2012.01760.x","volume":"83","author":"DM Teti","year":"2012","unstructured":"Teti DM, Crosby B . Maternal depressive symptoms, dysfunctional cognitions, and infant night waking: the role of maternal nighttime behavior. Child Dev 2012;83:939\u201353.","journal-title":"Child Dev"},{"key":"BFpr2017156_CR33","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.111.3.e203","volume":"111","author":"P Lam","year":"2003","unstructured":"Lam P, Hiscock H, Wake M . Outcomes of infant sleep problems: a longitudinal study of sleep, behavior, and maternal well-being. Pediatrics 2003;111:e203\u20137.","journal-title":"Pediatrics"},{"key":"BFpr2017156_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1523-536X.2003.00243.x","volume":"30","author":"HL Ball","year":"2003","unstructured":"Ball HL . Breastfeeding, bed-sharing, and infant sleep. Birth 2003;30:181\u20138.","journal-title":"Birth"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2017156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:50Z","timestamp":1684616570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2017156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFpr2017156"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.156","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]},"assertion":[{"value":"13 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MG has previously received honorarium for speaking from Lundbeck. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}